• Liam Noah posted an update in the group Group logo of HealthHealth 1 week, 3 days ago

    A Questionable 3-Year-Study Is Indicating That Common Diabetes Drug, Canagliflozin, With Brand Name, Invokana Could Also Reduce Risks Of Kidney Diseases And Cardiovascular Deaths In Folks With Type 2 Diabetes And Chronic Kidney Disease. But The Side Effects Of Invokana Could Be An Increased Risk Of Lower Limb Amputation And Bone Fracture.

    [Reference]

    Advertisement